Acusensus Limited develops, manufactures and markets innovative medical technologies and services to improve outcomes for patients and clinicians. Their core technologies include ultrasound imaging, image analysis and machine intelligence. Their projects and objectives focus on improving the detection, diagnosis and management of chronic diseases, such as cancer, cardiovascular disease and musculoskeletal conditions. They are committed to delivering transformative medical care to benefit both clinicians and patients.